InspirFit offers PD programs designed to increase or maintain the physical well-being of participants. The foundation provides a grant to the program.
Chicago Tribune: Parkinson's Patients Find Help at Willowbrook Fitness Facility
Parkinson’s Foundation Medical Director Dr. Okun weighs in on a recent Parkinson’s and hepatitis study.
NPF division’s Minnesota chapter and local NBC news host Dave Schwartz paired up to raise money for Parkinson’s Awareness month in a unique way.
NPF division’s Heartland chapter board member Denise Franklin talks about early warning signs, our Aware in Care hospitalization kit and Moving Day® Kansas City.
Neurology Now recently spoke with Parkinson’s Foundation new CEO, John Lehr, about the merged organization and his new job. John shared the Foundation’s insight on cutting-edge research and helping people with Parkinson’s live their best lives every day.
60 Minutes shows how con-artists insert fake news into the national conversation. NPF division is mentioned in relation to the rumor regarding Hillary Clinton and Parkinson’s.
In a study in the Journal of Parkinson's Disease, researchers determined that people with PD who exercised regularly had significantly slower declines in HRQL and mobility over a two-year period. Lead investigator Miriam R. Rafferty, PhD, of Northwestern University and Rehabilitation Institute of Chicago, a center of Excellence, describes the main findings of the study. NPF’s Parkinson’s Outcomes Project is mentioned.
Parkinson’s Foundation Medical Director Dr. Okun weighs in on the FDA approval of safinamide.
Six members of the Nash UNC Health Care rehabilitation team have attended training and are now certified in the LSVT BIG and LSVT LOUD programs thanks to an NPF division grant. NPF’s NC Triangle community development manager Blake Tedder is quoted.
The Tampa Bay Buccaneers have pledged their support to Moving Day® Tampa. In addition to donations of $5,000 and a Club Seat ticket package for the event's auction, the team is bringing the Bucs Squad Experience so young attendees can get moving, too.
A study led by Dr. Robert A. Hauser from the Parkinson’s Disease and Movement Disorders Center at the University of South Florida, a Center of Excellence, proved that participants who took an MAO-B inhibitor for a longer period experienced slower clinical decline.